Show Notes
In this episode of The Good GP, host Dr Sean Stevens speaks with Professor Nick Zwar, Chair of the RACGP Travel Medicine Specific Interest Group, to discuss the state of travel medicine in Australia post-COVID-19 pandemic. Professor Zwar outlines how the pandemic led to a sudden halt in international travel and impacted travel medicine practice. Many have adapted by shifting their focus back to general practice, advising patients stranded overseas, and planning for a resumption of travel. He also notes the practical implications, such as unused vaccine stock and the adoption of telehealth. Also discussing the resumption of international travel, with Australians returning to pre-pandemic travel levels, including higher-risk activities like cruise ship travel. They observe that despite the risks of infectious diseases, most patients are eager to travel and may not be as concerned about COVID-19 as practitioners might expect. Looking ahead, Professor Zwar identifies several challenges in travel medicine. These include changing patterns of infectious diseases (notably respiratory infections, dengue fever, Japanese encephalitis, and measles), emerging threats like monkeypox (Mpox), and the increasing prevalence of antimicrobial resistance affecting management of traveler's diarrhoea. He also highlights the complexity of advising immunocompromised travellers, particularly those on biological therapies. The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our instagram page: @thegoodgppodcast. Follow us for more updates!
More from The Good GP
In this episode of The Good GP, Dr Krystyna de Lange speaks with Dr Steph Daly, GP with a special interest in aged care and dementia, about the introduction of plasma biomarkers, specifically the p-Tau 217 blood test for Alzheimer’s disease. They explore what the p-Tau 217 test measures, its reliability, and its role in primary care.
In this episode of The Good GP, host Dr Krystyna De Lange speaks with Dr David Leitinger, a GP with a special interest in addiction medicine, about the practical use of naltrexone for managing alcohol use disorder (AUD).
In this episode of The Good GP, Dr Julia Rawlinson speaks with Dr Florence Martin, an epidemiologist specialising in pregnancy pharmacoepidemiology. Dr Martin discusses her recent study examining the relationship between first trimester antidepressant use and miscarriage risk, using UK primary care data from the CPRD GOLD database.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Julia Feutrill, consultant psychiatrist at King Edward Memorial Hospital and co-director of the Elizabeth Clinic. They discuss the complexities of antidepressant use during pregnancy, providing GPs with practical advice for navigating these conversations.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Paul Effler, Senior Medical Advisor at the WA Department of Health and expert in communicable diseases, about H5N1 avian influenza and pertussis.